Phase II trial of levocetirizine with capecitabine and bevacizumab to overcome the resistance of antiangiogenic therapies in refractory metastatic colorectal cancer.
J Gastrointest Oncol
; 10(3): 412-420, 2019 Jun.
Article
in En
| MEDLINE
| ID: mdl-31183190
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
/
Prognostic_studies
Language:
En
Journal:
J Gastrointest Oncol
Year:
2019
Type:
Article
Affiliation country:
United States